Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;184(12):3163-9.
doi: 10.1016/j.ajpath.2014.08.018. Epub 2014 Oct 3.

Blood vascular abnormalities in Rasa1(R780Q) knockin mice: implications for the pathogenesis of capillary malformation-arteriovenous malformation

Affiliations

Blood vascular abnormalities in Rasa1(R780Q) knockin mice: implications for the pathogenesis of capillary malformation-arteriovenous malformation

Beth A Lubeck et al. Am J Pathol. 2014 Dec.

Abstract

Capillary malformation-arteriovenous malformation (CM-AVM) is an autosomal dominant blood vascular (BV) disorder characterized by CM and fast flow BV lesions. Inactivating mutations of the RASA1 gene are the cause of CM-AVM in most cases. RASA1 is a GTPase-activating protein that acts as a negative regulator of the Ras small GTP-binding protein. In addition, RASA1 performs Ras-independent functions in intracellular signal transduction. Whether CM-AVM results from loss of an ability of RASA1 to regulate Ras or loss of a Ras-independent function of RASA1 is unknown. To address this, we generated Rasa1 knockin mice with an R780Q point mutation that abrogates RASA1 catalytic activity specifically. Homozygous Rasa1(R780Q/R780Q) mice showed the same severe BV abnormalities as Rasa1-null mice and died midgestation. This finding indicates that BV abnormalities in CM-AVM develop as a result of loss of an ability of RASA1 to control Ras activation and not loss of a Ras-independent function of this molecule. More important, findings indicate that inhibition of Ras signaling is likely to represent an effective means of therapy for this disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Generation of Rasa1R780Q knockin allele in mice. A: Exon-intron organization of the murine Rasa1 gene (top) and RASA1 protein (bottom). The positions of the R780Q and R780Q mutations in exon 18 and the GAP domain, respectively, are indicated. B: An R780Q targeting vector with an R780Q mutation in exon 18 and a FRT-flanked NeoR cassette in intron 18 is shown below the endogenous allele. At middle is shown the R780Q targeted allele before and after excision of the NeoR cassette achieved with an actin promoter-driven Flp transgene (Act-Flp). At bottom is depicted a Rasa1 floxed allele in which exon 18 is flanked by loxP sites. Positions of real-time PCR primer/probe pairs used in the detection of ES cell homologous recombinants and PCR primer pairs used in mouse genotyping are indicated. C2, protein kinase C2 homology; GAP, GTPase-activating protein domain; PH, pleckstrin homology; SH2, Src homology 2; SH3, Src homology 3.
Figure 2
Figure 2
Embryonic lethality of homozygous Rasa1R780Q mice. A:Rasa1R780Q/fl mice were intercrossed. Tail genomic DNA from progeny at 3 weeks of age was PCR amplified using genotyping primers indicated in Figure 1. Genotyping results from two Rasa1R780Q/fl (fl/rq) pups and one Rasa1fl/fl (fl/fl) pup are depicted. B: Graphs show the total number of pups of the indicated genotypes derived from intercrosses of Rasa1R780Q/fl mice determined at 3 weeks after birth and at E9.5, E11, and E13.5 of development. At E9.5, genotype frequencies are consistent with mendelian inheritance (χ2 test). At E11, E13.5, and 3 weeks of age, genotype frequencies are not consistent with mendelian inheritance (P < 0.025, P < 0.05, and P < 0.005, respectively). C and D: Light microscopic appearance (C) and hematoxylin and eosin (H&E)–stained sections (D) of Rasa1R780Q/R780Q and Rasa1R780Q/fl embryos and yolk sacs at E9.5. Features to note include reduced size and distended pericardial sac (arrow) and wrinkled appearance of the yolk sac of Rasa1R780Q/R780Q embryos. E: MEFs derived from E9.5 Rasa1R780Q/R780Q and Rasa1fl/fl embryos were analyzed for RASA1 protein abundance by using Western blot analysis. Blots were reprobed for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to show equivalent protein loading. Shown are RASA1 amounts in MEF derived from two different embryos of each genotype. E, embryo proper; YS, yolk sac.
Figure 3
Figure 3
Cardiovascular abnormalities in homozygous Rasa1R780Q mice. A and B: Whole mount (A) and sections (B) of E9.5 Rasa1R780Q/R780Q and Rasa1fl/fl embryos were stained with an anti-CD31 antibody to reveal blood vasculature. A: Note the organized BV network in the Rasa1fl/fl yolk sac (YS) and honeycombed appearance of blood vasculature in the Rasa1R780Q/R780Q yolk sac (asterisk). Note also irregular blood vasculature in the Rasa1R780Q/R780Q embryo proper (E). B: Note the disorganized dorsal aorta in the Rasa1R780Q/R780Q embryo compared with the Rasa1fl/fl embryo (arrows). DA, dorsal aorta; IS, intersegmental artery.
Figure 4
Figure 4
MAPK activation in homozygous Rasa1R780Q embryos. Tissue sections of E9.5 Rasa1R780Q/R780Q and Rasa1fl/fl embryos were stained with anti-CD31 (red) and anti–phospho-ERK (green) antibodies. Shown are select regions of embryos that include part of the dorsal aorta (arrows). Note the absence of pERK staining in most ECs in Rasa1fl/fl embryos and the presence of pERK staining in most ECs in Rasa1R780Q/R780Q embryos.

Similar articles

Cited by

References

    1. Eerola I., Boon L.M., Mulliken J.B., Burrows P.E., Dompmartin A., Watanabe S., Vanwijck R., Vikkula M. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003;73:1240–1249. - PMC - PubMed
    1. Revencu N., Boon L.M., Mulliken J.B., Enjolras O., Cordisco M.R., Burrows P.E., Clapuyt P., Hammer F., Dubois J., Baselga E., Brancati F., Carder R., Quintal J.M., Dallapiccola B., Fischer G., Frieden I.J., Garzon M., Harper J., Johnson-Patel J., Labreze C., Martorell L., Paltiel H.J., Pohl A., Prendiville J., Quere I., Siegel D.H., Valente E.M., Van Hagen A., Van Hest L., Vaux K.K., Vicente A., Weibel L., Chitayat D., Vikkula M. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008;29:959–965. - PubMed
    1. Revencu N., Boon L.M., Mendola A., Cordisco M.R., Dubois J., Clapuyt P. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat. 2013;34:1632–1641. - PubMed
    1. Bayrak-Toydemir P, Stevenson D: RASA1-Related Disorders. Edited by RA Pagon, MP Adam, HH Ardinger, et al. In GeneReviews [Internet]. Copyright University of Washington, Seattle. 2011. Available at http://www.ncbi.nlm.nih.gov/books/NBK52764, last revised December 19, 2013
    1. de Wijn R.S., Oduber C.E., Breugem C.C., Alders M., Hennekam R.C., van der Horst C.M. Phenotypic variability in a family with capillary malformations caused by a mutation in the RASA1 gene. Eur J Med Genet. 2012;55:191–195. - PubMed

Substances

Supplementary concepts